Evoke Pharma Balance Sheet - Quarterly (NASDAQ:EVOK)

Add to My Stocks
$2.06 $0 (0%) EVOK stock closing price Mar 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Evoke Pharma balance sheet. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Evoke Pharma stock analysis, and provides insights into the firm's financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. The balance sheet shows total liabilities of $8.69M and shareholders equity of $2.05M. Evoke Pharma revenue and Evoke Pharma operating cash flow are important in understanding the financial capacity of the company.

View and download Evoke Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Marketable Securities---------
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets---------
Total Current Assets
Property Plant & Equipment---------
Accumulated Depreciation---------
Net Property Plant & Equipment
Investment & Advances---------
Other Non-Current Assets---------
Deferred Charges---------
Deposits & Other Assets---------
Total Assets
Notes Payable---------
Accounts Payable1.72M1.12M---1.26M1.24M-1.33M
Current Portion Long-Term Debt-----4.39M---
Current Portion Capital Leases---------
Accrued Expenses---------
Income Taxes Payable---------
Other Current Liabilities---------
Total Current Liabilities
Deferred Taxes/Income---------
Convertible Debt---------
Long-Term Debt------3.68M4.23M4.36M
Non-Current Capital Leases---------
Other Long-Term Liabilities6.05M4.5M5.76M4.09M5.09M----
Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus72.78M72.25M71.79M62.59M61.98M52.72M52.04M51.52M50.74M
Retained Earnings-70.73M-65.48M-63.86M-58.8M-57.28M-54.25M-51.28M-48.06M-45.43M
Treasury Stock---------
Other Liabilities---------
Shareholders Equity2.05M6.76M7.93M3.78M4.7M-1.52M-3.46M5.3M
Total Liabilities & Shareholders Equity10.75M13.15M14.83M9.29M10.81M4.63M6.87M9.53M11.68M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the Evoke Pharma stock price, and Evoke Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Evoke Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: EVOK total assets, which was at $10.75M for 2017 Q3 is a balance sheet item representing value of what Evoke Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Evoke Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for EVOK stock stand at $8.69M.

Evoke Pharma Balance Sheet - Key Ratios